May 29, 2026

AI Shows Promise for Intraoperative Lung Adenocarcinoma Assessment

A smartphone image–centered deep learning model showed promise for intraoperative diagnosis and grading of clinical stage IA lung adenocarcinoma, but grade-specific limitations and lack of outcomes data mean the tool remains investigational.

Conexiant

May 20, 2026

FDA Approves Expanded Liquid Biopsy Panel

Updated liquid biopsy combines genomic and epigenomic profiling for companion diagnostic use across multiple tumor types.

Conexiant

May 15, 2026

Why FDA Said No to a Melanoma Drug

Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.

Kff Health News

May 13, 2026

AI May Improve Breast Mitotic Scoring

Junior pathologists showed higher mitotic score accuracy and agreement with artificial intelligence assistance in a preliminary single-center reader study

Conexiant

May 12, 2026

Frozen Section in Endometrial Care?

Systematic review examines intraoperative biopsy accuracy across endometrial pathologies and diagnostic settings.

Conexiant

May 11, 2026

Automated Staining Aids Real-Time Tumor Calls

Automated frozen-section staining helped classify selected ambiguous tumors and margins in a single-center validation study.

Conexiant

May 11, 2026

Folate Biomarkers Linked to Lung Cancer

Cross-sectional NHANES analysis found associations between select folate markers and self-reported physician-diagnosed lung cancer, though the direction and clinical significance of the relationship remain unclear

Conexiant

May 08, 2026

Vaginal DNA Assay Shows Promise

A two-marker methylated DNA assay identified endometrial cancer with 96% sensitivity in self-collected vaginal fluid — but prospective validation is needed before it can reduce biopsies in routine care.

Conexiant

May 08, 2026

Reduced-Dose Radiation Shows Durable Control

Single-arm cohort findings contrast with interim results from NRG-HN005, underscoring ongoing uncertainty around treatment deintensification.

Conexiant

May 05, 2026

PET/CT and MRI Model May Help Stratify Prostate Cancer Risk

Retrospective multicenter radiomics study showed moderate to high discrimination in two small external cohorts

Conexiant